Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 201: SHL Medical’s Investment in the Carolinas with Kimberlee Steele of SHL Medical
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 174: Artificial Intelligence in Healthcare with Jonathan Samples, Partner at 121G
Health + Tech - Future of Precision Medicine With Dr. Amrie Grammer
Podcast: Discussing Information Blocking with Eddie Williams
Podcast - Artificial Intelligence in Healthcare and How to Comply with HIPAA & State Privacy Laws
Health + Tech - How Digital Health Tools Help Create Greater Consumer Focus in Healthcare
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 118: Matthew Roberts and Darra Coleman, Health Care Attorneys, Nexsen Pruet
Expanded Information Block Rules Go into Effect
5 Key Takeaways | Current Perspectives Around the Convergence of Life Sciences and IT
Podcast: Interoperability: Health Care's Next Disruptor Is openEHR - Diagnosing Health Care
Podcast: Interoperability: A New Vision Through openEHR - Diagnosing Health Care
Podcast: Interoperability - the Role of Health Information Exchanges - Diagnosing Health Care
AGG Talks: Technology - In the Balance: Interoperability and Security
Health+Tech - Episode 4: Exploring Recent Changes in Interoperability and Information Blocking
Health+Tech - Episode 2: Edge of Digital Health Transformation
What can Technology do for Your Practice?
Compliance Perspectives: The Ethics of Data
Information Blocking: How Will the New Rule Impact the Health Care Industry?
From NC State to Changing the State of Health Information Networks, with Medicom Technologies’ Malcolm Benitz
Exploring Digitization of Health and Medical Data and Records Part One
On January 5, 2018, the United States Department of Health and Human Services released for public comment a draft Trusted Exchange Framework, which seeks to accomplish interoperability with respect to patients’ Electronic...more
The FDA recently published two draft guidance documents to clarify which types of medical software, based on their functionality, are no longer considered medical devices as a result of the changes imposed under section 3060...more
The December 8, 2016 passage of the 21st Century Cures Act by Congress is expected to lead to sweeping changes to the biotech, medical device and health industries and streamline the regulatory system for approval of both...more
On December 13, 2016, President Obama signed into law the 21st Century Cures Act (Act), one of the most important pieces of health care and life sciences legislation in several decades. The Act is intended to spur the rapid...more
The 21st Century Cures Act encourages biomedical research investment and facilitates innovation review and approval processes, but also serves as a vehicle for a wide variety of other health-related measures, including...more
Ways & Means Leadership Changes – Health Policy Implications Looming: As Congress pushes forward with a two-year budget deal, and new Speaker Paul Ryan begins his tenure as the top Republican in the House of...more
On July 10, 2015, the House of Representatives passed the 21st Century Cures Act, which modifies Food and Drug Administration (FDA) processes, provides funding for the FDA and the National Institutes of Health (NIH), includes...more
On July 10, 2015, the House of Representatives passed the 21st Century Cures Act by a vote of 344-77. The bill is intended to promote drug and device development, support research and expedite patients’ access to new...more